These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3134111)

  • 1. Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to D-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens.
    Simon H; Taghzouti K; Gozlan H; Studler JM; Louilot A; Herve D; Glowinski J; Tassin JP; Le Moal M
    Brain Res; 1988 May; 447(2):335-40. PubMed ID: 3134111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intra-accumbens dopaminergic grafts on behavioral deficits induced by 6-OHDA lesions of the nucleus accumbens or A10 dopaminergic neurons: a comparison.
    Herman JP; Choulli K; Abrous N; Dulluc J; Le Moal M
    Behav Brain Res; 1988 Jul; 29(1-2):73-83. PubMed ID: 3401324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to amphetamine and facilitation of amphetamine self-administration after 6-hydroxydopamine lesions of the amygdala.
    Deminière JM; Taghzouti K; Tassin JP; Le Moal M; Simon H
    Psychopharmacology (Berl); 1988; 94(2):232-6. PubMed ID: 3127850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.
    Taylor JR; Robbins TW
    Psychopharmacology (Berl); 1986; 90(3):390-7. PubMed ID: 3097729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of dopaminergic activity in the nucleus accumbens following facilitation or blockade of the dopaminergic transmission in the amygdala: a study by in vivo differential pulse voltammetry.
    Louilot A; Simon H; Taghzouti K; Le Moal M
    Brain Res; 1985 Oct; 346(1):141-5. PubMed ID: 2996703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration.
    Lyness WH; Friedle NM; Moore KE
    Pharmacol Biochem Behav; 1979 Nov; 11(5):553-6. PubMed ID: 531077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation.
    Olds ME
    Neuroscience; 1990; 35(2):313-25. PubMed ID: 2199840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
    Whishaw IQ; Fiorino D; Mittleman G; Castañeda E
    Brain Res; 1992 Mar; 576(1):1-11. PubMed ID: 1381257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of ventral pallidal neurons to amygdala stimulation and its modulation by dopamine projections to nucleus accumbens.
    Yim CY; Mogenson GJ
    J Neurophysiol; 1983 Jul; 50(1):148-61. PubMed ID: 6875644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW; Bronson M
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei.
    Makanjuola RO; Ashcroft GW
    Psychopharmacology (Berl); 1982; 76(4):33-40. PubMed ID: 6812107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study.
    Louilot A; Le Moal M; Simon H
    Neuroscience; 1989; 29(1):45-56. PubMed ID: 2710347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine.
    Burns LH; Robbins TW; Everitt BJ
    Behav Brain Res; 1993 Jun; 55(2):167-83. PubMed ID: 8357526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine.
    Clarke PB; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1988; 96(4):511-20. PubMed ID: 3149775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens.
    Tassin JP; Simon H; Hervé D; Blanc G; Le Moal M; Glowinski J; Bockaert J
    Nature; 1982 Feb; 295(5851):696-8. PubMed ID: 6276780
    [No Abstract]   [Full Text] [Related]  

  • 18. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential and asymmetrical behavioral effects of electrolytic or 6-hydroxydopamine lesions in the nucleus accumbens.
    Kubos KL; Moran TH; Robinson RG
    Brain Res; 1987 Jan; 401(1):147-51. PubMed ID: 3101978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.